Open-Label Clinical Trial Evaluating the Impact of a Multi-Strain Commensal Probiotic Dietary Supplement on Gastrointestinal Microbiota Composition, Functional Gastrointestinal Markers, and Gastrointestinal Symptoms
Part of paid clinical trials in Richmond, Virginia.
- Sponsor
- OvationLab
- Study ID
- NCT07720362
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Gastrointestinal
- Microbiota
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Complete Commensal Probiotic — DIETARY_SUPPLEMENTComplete Commensal Probiotic™ contains five established commensal strains selected for their documented physiologic roles in the healthy adult gut. The five commensal strains in the product in this study are Akkermansia muciniphila (TA09), Bifidobacterium adolescentis (TA38), Bifidobacterium longum (TA24), Faecalibacterium prausnitzii (TA35), and Roseburia intestinalis (TA08).
Study Details
A single-arm, open-label prospective study will be conducted evaluating the impact of 8 weeks of supplementation at the manufacturer-recommended dose of Complete Commensal Probiotic™ on the GI-MAP stool test panel (Diagnostic Solutions Laboratory, Alpharetta, GA), gastrointestinal symptoms, digestion-associated quality of life. and overall physical health, mental health, and anxiety.
Key Dates
- First listed
- Jul 22, 2026
- Start date
- Jul 21, 2026
- Status verified
- Jul 2026
- Primary completion
- Nov 30, 2026
- Completion
- Nov 30, 2026
Study Design
- Enrollment
- 25 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: Complete Commensal Probiotic
Primary Outcome Measure
Relative Abundance of Commensal Microorganisms [ Time Frame: Baseline and end of 8-week intervention ]
Central Contacts
- Study Administrator(240) 232-2103
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| OvationLab | Richmond | Virginia | 23220 |
Find similar trials in Richmond, VA
Related Studies
- Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates.PHASE1/PHASE2 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Falls Church, Virginia
- Terraflora Daily Care and Gastrointestinal HealthRecruiting · OvationLab · Richmond, Virginia
- Capillary Endoscopy Aspiration CatheterRecruiting · Cedars-Sinai Medical Center · Los Angeles, California
- Impact of Dietary Intervention on Inflammation and Microbiome Composition Post-ColonoscopyEnrolling By Invitation · University of California, San Diego · San Diego, California